Stifel Financial Corp Has $43,000 Stock Position in agilon health, inc. (NYSE:AGL)

Stifel Financial Corp lessened its holdings in shares of agilon health, inc. (NYSE:AGL) by 41.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 10,875 shares of the company’s stock after selling 7,607 shares during the quarter. Stifel Financial Corp’s holdings in agilon health were worth $43,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Arizona State Retirement System increased its holdings in shares of agilon health by 2.5% in the second quarter. Arizona State Retirement System now owns 85,989 shares of the company’s stock worth $562,000 after acquiring an additional 2,070 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new stake in agilon health during the 3rd quarter worth approximately $28,000. Signaturefd LLC raised its holdings in agilon health by 166.2% during the 2nd quarter. Signaturefd LLC now owns 11,848 shares of the company’s stock worth $77,000 after buying an additional 7,398 shares during the period. Wedbush Securities Inc. increased its position in shares of agilon health by 72.6% during the second quarter. Wedbush Securities Inc. now owns 20,710 shares of the company’s stock worth $135,000 after acquiring an additional 8,710 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC raised its holdings in shares of agilon health by 17,790.0% during the second quarter. Allspring Global Investments Holdings LLC now owns 10,734 shares of the company’s stock worth $70,000 after acquiring an additional 10,674 shares during the period.

Insiders Place Their Bets

In other news, Director John William Wulf acquired 45,000 shares of the firm’s stock in a transaction on Thursday, December 5th. The shares were purchased at an average cost of $2.18 per share, with a total value of $98,100.00. Following the acquisition, the director now directly owns 206,133 shares in the company, valued at $449,369.94. This represents a 27.93 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Diana Mckenzie bought 12,500 shares of the company’s stock in a transaction dated Monday, November 25th. The shares were purchased at an average cost of $2.28 per share, with a total value of $28,500.00. Following the acquisition, the director now directly owns 51,319 shares of the company’s stock, valued at approximately $117,007.32. This represents a 32.20 % increase in their position. The disclosure for this purchase can be found here. Insiders purchased 90,000 shares of company stock worth $198,100 over the last three months. Insiders own 3.20% of the company’s stock.

agilon health Stock Up 0.5 %

AGL stock opened at $1.91 on Tuesday. agilon health, inc. has a 1-year low of $1.50 and a 1-year high of $13.28. The business’s 50 day simple moving average is $2.18 and its 200 day simple moving average is $4.05. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The firm has a market capitalization of $786.95 million, a PE ratio of -2.03 and a beta of 0.51.

agilon health (NYSE:AGL) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The company had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same period in the previous year, the company earned ($0.06) earnings per share. As a group, research analysts anticipate that agilon health, inc. will post -0.52 EPS for the current year.

Wall Street Analyst Weigh In

AGL has been the subject of a number of research analyst reports. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $3.00 target price on shares of agilon health in a research note on Tuesday, November 19th. Stifel Nicolaus cut their target price on agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a research note on Tuesday, November 12th. JMP Securities cut shares of agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday, November 11th. William Blair downgraded shares of agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. Finally, Macquarie started coverage on shares of agilon health in a report on Monday, December 16th. They set a “neutral” rating and a $3.00 target price for the company. Three equities research analysts have rated the stock with a sell rating, sixteen have issued a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $4.28.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.